ProQR Therapeutics BV (PRQR) — Capital Reinvestment Ratio
ProQR Therapeutics BV (PRQR) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($44.73 Million) in capital expenditures ($136.00K). See net asset quality index of ProQR Therapeutics BV to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ProQR Therapeutics BV Capital Reinvestment Ratio (2023–2023)
This chart tracks ProQR Therapeutics BV's Capital Reinvestment Ratio across 1 annual periods. Check how aggressively does ProQR Therapeutics BV reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for ProQR Therapeutics BV (2023–2023)
Year-by-year Capital Reinvestment Ratio for ProQR Therapeutics BV from 2023 to 2023. For live market cap and broader valuation context, see market value of ProQR Therapeutics BV.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.06x | $21.55 Million | $1.37 Million | — |